Annual CAPEX
$1.05 M
+$883.00 K+538.41%
31 December 2023
Summary:
Lyra Therapeutics annual capital expenditures is currently $1.05 million, with the most recent change of +$883.00 thousand (+538.41%) on 31 December 2023. During the last 3 years, it has fallen by -$728.00 thousand (-41.01%). LYRA annual CAPEX is now -69.07% below its all-time high of $3.38 million, reached on 31 December 2021.LYRA CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
$51.00 K
-$145.00 K-73.98%
30 September 2024
Summary:
Lyra Therapeutics quarterly capital expenditures is currently $51.00 thousand, with the most recent change of -$145.00 thousand (-73.98%) on 30 September 2024. Over the past year, it has dropped by -$93.00 thousand (-64.58%). LYRA quarterly CAPEX is now -97.63% below its all-time high of $2.15 million, reached on 31 March 2024.LYRA Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
$3.18 M
-$93.00 K-2.84%
30 September 2024
Summary:
Lyra Therapeutics TTM capital expenditures is currently $3.18 million, with the most recent change of -$93.00 thousand (-2.84%) on 30 September 2024. Over the past year, it has increased by +$2.90 million (+1005.21%). LYRA TTM CAPEX is now -2.84% below its all-time high of $3.28 million, reached on 30 June 2024.LYRA TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LYRA CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +538.4% | -64.6% | +1005.2% |
| 3 y3 years | -41.0% | -90.1% | +515.7% |
| 5 y5 years | +2729.7% | - | - |
LYRA CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -69.1% | +538.4% | -97.6% | +264.3% | -2.8% | +2644.0% |
| 5 y | 5 years | -69.1% | +2729.7% | -97.6% | +264.3% | -2.8% | +2644.0% |
| alltime | all time | -69.1% | +2729.7% | -97.6% | +264.3% | -2.8% | +2644.0% |
Lyra Therapeutics CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $51.00 K(-74.0%) | $3.18 M(-2.8%) |
| June 2024 | - | $196.00 K(-90.9%) | $3.28 M(+4.0%) |
| Mar 2024 | - | $2.15 M(+173.1%) | $3.15 M(+201.0%) |
| Dec 2023 | $1.05 M(+538.4%) | $787.00 K(+446.5%) | $1.05 M(+263.5%) |
| Sept 2023 | - | $144.00 K(+102.8%) | $288.00 K(+66.5%) |
| June 2023 | - | $71.00 K(+57.8%) | $173.00 K(+49.1%) |
| Mar 2023 | - | $45.00 K(+60.7%) | $116.00 K(-29.3%) |
| Dec 2022 | $164.00 K | $28.00 K(-3.4%) | $164.00 K(-86.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | $29.00 K(+107.1%) | $1.22 M(-28.6%) |
| June 2022 | - | $14.00 K(-84.9%) | $1.71 M(+0.8%) |
| Mar 2022 | - | $93.00 K(-91.4%) | $1.69 M(+5.8%) |
| Dec 2021 | $3.38 M(+90.7%) | $1.08 M(+109.5%) | $1.60 M(+209.5%) |
| Sept 2021 | - | $517.00 K | $517.00 K |
| Dec 2020 | $1.77 M(+741.2%) | - | - |
| Dec 2019 | $211.00 K(+470.3%) | - | - |
| Dec 2018 | $37.00 K | - | - |
FAQ
- What is Lyra Therapeutics annual capital expenditures?
- What is the all time high annual CAPEX for Lyra Therapeutics?
- What is Lyra Therapeutics annual CAPEX year-on-year change?
- What is Lyra Therapeutics quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Lyra Therapeutics?
- What is Lyra Therapeutics quarterly CAPEX year-on-year change?
- What is Lyra Therapeutics TTM capital expenditures?
- What is the all time high TTM CAPEX for Lyra Therapeutics?
- What is Lyra Therapeutics TTM CAPEX year-on-year change?
What is Lyra Therapeutics annual capital expenditures?
The current annual CAPEX of LYRA is $1.05 M
What is the all time high annual CAPEX for Lyra Therapeutics?
Lyra Therapeutics all-time high annual capital expenditures is $3.38 M
What is Lyra Therapeutics annual CAPEX year-on-year change?
Over the past year, LYRA annual capital expenditures has changed by +$883.00 K (+538.41%)
What is Lyra Therapeutics quarterly capital expenditures?
The current quarterly CAPEX of LYRA is $51.00 K
What is the all time high quarterly CAPEX for Lyra Therapeutics?
Lyra Therapeutics all-time high quarterly capital expenditures is $2.15 M
What is Lyra Therapeutics quarterly CAPEX year-on-year change?
Over the past year, LYRA quarterly capital expenditures has changed by -$93.00 K (-64.58%)
What is Lyra Therapeutics TTM capital expenditures?
The current TTM CAPEX of LYRA is $3.18 M
What is the all time high TTM CAPEX for Lyra Therapeutics?
Lyra Therapeutics all-time high TTM capital expenditures is $3.28 M
What is Lyra Therapeutics TTM CAPEX year-on-year change?
Over the past year, LYRA TTM capital expenditures has changed by +$2.90 M (+1005.21%)